25 MediCities could create 4 lakh jobs: Primus Partners Report

IMT News Desk
IMT News Desk
· 2 min read
People walking and sitting at hospital building. City clinic glass exterior. Flat vector illustration for medical help, emergency, architecture, healthcare concept

These MediCities will plug India’s healthcare infrastructure gap

Primus Partners has launched its latest thought leadership report, ‘Shaping India’s Future: Healthcare and Social Equity for All by 2047’, outlining a broad roadmap to establish 25 integrated MediCities across India by 2047.

Planned as a PPP-driven (public-private partnership) healthcare ecosystem, these MediCities will plug India’s healthcare infrastructure gap. Simultaneously, they will support employment and medical research opportunities to position India as a global destination for tertiary and affordable care.

Some key highlights of the report:

• Rs 85,000 crore investment: Rs 10,000 crore from the Central Government for common infrastructure; Rs 75,000–80,000 crore expected from private companies for core medical facilities and education.

• Employment generation: A single 200-acre MediCity could generate 75,000 jobs (30,000 direct and 45,000 indirect); across 25 hubs, this translates to 4 lakh+ direct jobs.

• Universal healthcare: 25 per cent of beds in each MediCity are likely to be reserved for affordable treatment under the Central Government Health Scheme.

• Medical tourism boost: With more than 6.3 lakh international medical tourists in 2023, MediCities near Tier-I and Tier-II airports could double this number by 2029.

• Sustainable urban planning: Built around ‘Walk-to-Hospital’ ecosystems, with residential, wellness, diagnostic and educational facilities integrated into a single zone.

Nilaya Varma, Group CEO, Primus Partners, said, “The MediCities concept offers a compelling case for transforming India’s healthcare access and economic development. With more than Rs 85,000 crore in potential investment and 4 lakh direct jobs, this initiative aligns with the Centre’s vision for Viksit Bharat and the broader goals of Amritkaal, promoting affordable care, attracting patients from across the globe, and driving inclusive growth across sectors.”

The MediCity proposal includes an SPV (Special Purpose Vehicle) jointly owned by the Government of India and State Governments (50:50 ratio). Each MediCity will accommodate up to 5,000 beds, medical colleges, diagnostics and support infrastructure such as pharmacies, hostels and common utilities.

MediCities will also play a pivotal role in enhancing India’s Medical Value Tourism. Valued at $7.69 billion in 2024, this segment is projected to reach $14.31 billion by FY2028–29. Cities close to international airports will be strong candidates for development. Furthermore, by promoting universal healthcare access, MediCities will ensure ‘Sabka Swasth’ by 2047.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk